-

About FDA

  • Share Share this page

SMG 1117.442

FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS

FOOD AND DRUG ADMINISTRATION

OFFICE OF THE COMMISSIONER

OFFICE OF OPERATIONS

OFFICE OF FINANCIAL MANAGEMENT

OFFICE OF FINANCIAL SERVICES

DIVISION OF PAYMENT SERVICES

Effective Date: 01/13/2009

1. DIVISION OF PAYMENT SERVICES (DAMGDB).

A. Performs billing and collecting services for headquarters accounts. Maintains internal control over processing of transactions to accounts, including application of batch controls to ensure accurate coding and making of necessary accounting transaction adjustments and corrections.

B. Maintains liaison with the Department of Central Payroll on headquarters payroll operations. Reconciles payroll data with accounts. Maintains tax withholding files. Issues withholding statements.

C. Processes employee time records; resolves payroll errors and assists employees with pay problems; issues new procedures as needed.

D. Participates in reengineering the payroll process to streamline correction of errors and reduce first time errors; and participates in timekeeper training.

E. Processes all purchase orders, receiving reports, and invoices for commercial payments made by the Food and Drug Administration (FDA) headquarters, assuring compliance with accounts and the Prompt Pay Act.

F. Coordinates with vendor and center personnel in researching payment information.

G. Responds to all vendor inquiries as well as inquiries from center personnel.

H. Prepares various reconciliations to ensure that schedules are properly accounted for and entered into the accounting system.

I. Reviews and distributes monthly accounting reports and processes corrections, as necessary.

J. Liaison with the Department of Treasury to initiate checks traces.

2. AUTHORITY AND EFFECTIVE DATE.

The functional statements for this Office were approved by the Commissioner, Food and Drug, effective January 13, 2009.

STATUS (I, R, C) DATE APPROVED LOCATION OF CHANGE HISTORY CONTACT APPROVING OFFICIAL
Initial 01/13/2009 N/a OC/OO/OM/OMP Commissioner of the Food and Drug Administration
    
-
-
-
-
-